Blood Stream Infection Testing Market - Global Forecast to 2026, by Product Type (Instruments, Reagents, and Others), by Technology (Conventional Testing and Non-Conventional Testing), by Test Type (Conventional Blood Culture Tests, PCR Method, Nucleic Acid Testing, Mass Spectroscopy, and Point-of-Care Testing), by End User (Hospitals, Independent Diagnostics Centers, and Others) - Size, Share, Trends, and Forecast 2019 - 2026

  • Published On : Jul 2019 |
  • Pages : 178 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Global Blood Stream Infection Testing Market

Blood stream infection is a condition where any bacterial, fungal or any type of infection is detected in the blood. The condition is evident when the infection enters into the blood stream of any part of the body. The bacteria or organisms that causes the blood infection are determined by using blood stream infection testing. There is major risk to human health because as there is rise in human population the hygiene level lowers which leads to the occurrence of various infectious diseases. According to the World Bank 2016 report, the population has reached up to 7.44 billion globally. This rising population leads to fuel the growth of the blood stream infection testing market. Self-diagnosis of bloodstream infections is difficult to because of its common symptoms like chills, cold, fever, diarrhea, vomiting. This reasons are needed to make testing mandatory for the detection of the infection in the bloodstream. This leads to boost the market growth. The blood stream infection tester tracks antibiotic resistance markers in bacteria. It is also used to diagnose sepsis.

The global blood stream infection testing market size was valued at US$ 3,758.7 million in 2017, and is expected to exhibit a CAGR of 8.4% over the forecast period (2019 – 2026).

Figure 1. Blood Stream Infection Testing Market Value (US$ Mn), by Region, 2017

Blood Stream Infection Testing  | Coherent Market Insights

                                                                      Source: Coherent Market Insights Analysis (2019)

Increasing prevalence of abdominal infection, dental infection, and chronic diseases is expected to propel the blood stream infection testing market growth

Overpopulated and insufficient shelters are the major factors causing transmission of diseases. Moreover, increasing awareness about chronic diseases such as cancer, HIV, and pneumonia that require blood tests at regular intervals of time is expected to boost growth of the market. Innovations, research and development investments, mergers and acquisitions of the key vendors help to boost growth of the blood stream infection testing market.

High demand for technologically advanced diagnostic tests, awareness about hygiene, diagnosis rate and unhealthy lifestyle are also expected to fuel the market growth over the forecast period.

However, rigid regulatory scenario related to diagnostic procedures, high diagnosis cost and lack of medical reimbursement may hinder the bloodstream infection testing market.

Figure 2. Blood Stream Infection Testing Market Share (%), by Product Type 2018 and 2026

Blood Stream Infection Testing  | Coherent Market Insights

                                                                  Source: Coherent Market Insights Analysis (2019)

Geographical expansion of blood stream infection testing manufacturers towards North America boost the market growth

On the basis of region, the global blood stream infection testing market is segmented into North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. North America held the dominant position in the global blood stream infection testing market in 2018, owing to preventive healthcare awareness and high adoption of the innovative products. Moreover, high diagnosis rate and developed medical facilities in this region also drives the growth of blood stream infection testing market in North America.

Moreover, Asia Pacific is expected to witness higher growth in the forecast period, owing to high prevalence of chronic diseases in the region. The wide availability of innovative products offering better solutions to patients at marginally lower costs also drives the blood stream infection testing market growth. For instance, in 2017, a group of researchers led by the National Cancer Center Japan (NCC), together with Toray Industries, Inc., developed a new method that could detect thirteen different cancer types with a single drop of blood.

Moreover, For instance, in 2017, Luminex Corporation announced that Japan’s Central Social Insurance Medical Council approved to provide reimbursement for two VERIGENE assays: the gram positive and negative blood culture test. This reimbursement is recommended by the Japanese Ministry of Health, Labor and Welfare. The VERIGENE system is able to detect pathogens from blood stream for various infectious diseases.    

Key Players

Major players operating in the blood stream infection testing market include, BioMérieux SA, Becton, Dickinson and Company, AB Sciex, IRIDICA, Abbot Laboratories, Cepheid Inc., C. R. Bard, Inc., F. Hoffmann-La Roche AG, Nanoshpere, Dade Behring, AdvanDX, and Siemens Healthcare.

Blood stream infection is a condition in which the blood is detected with bacterial, fungal, or any other infection. This condition normally occurs when the infection enters the blood stream of any part of body through wound, injection or during any surgical procedures. This infection is also considered as blood poisoning, bacteremia, septicemia, or sepsis. Self-diagnosis of blood stream infections is difficult, owing to its common symptoms (such as chills, fever, diarrhea, vomiting, and others), thereby testing is mandatory for detection of infections in blood.

Market Dynamics

Increasing prevalence of infections such as abdominal infections, dental infections, kidney and urinary infection, and chronic diseases drives the market growth. According to the World Health Organization (WHO), in 2016, over 30 million people are affected by sepsis worldwide, annually, leading to 6 million deaths. Moreover, increasing R&D investments related to blood stream infection testing is also expected to boost the market growth. Moreover, high incidences of burns/wounds cases, HIV, pneumonia, pyelonephritis, and cancer along with growing awareness about hygiene is also expected to boost the global blood stream infection testing market growth. According to World Health Organization, at the end of 2017, approximately 36.9 million people living with HIV and 1.8 million people becoming newly ininfected in 2017 globally. However, the high diagnostic costs and insufficiency medical reimbursement may hinder the market growth. 

Key features of the study:

  • This report provides in-depth analysis of the blood stream infection testing market and provides market size (US$ Mn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2019 – 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global blood stream infection testing market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans.
  • Key companies covered as a part of this study include, BioMérieux SA, Becton, Dickinson and Company, AB Sciex, IRIDICA, Abbot Laboratories, Cepheid Inc., C. R. Bard, Inc., F. Hoffmann-La Roche AG, Nanoshpere, Dade Behring, AdvanDX, Siemens Healthcare.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global blood stream infection testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the blood stream infection testing market

Detailed Segmentation:

  • Global Blood Stream Infection Testing Market, By Product Type:
    • Instruments
    • Reagents
    • Others
  • Global Blood Stream Infection Testing Market, By Technology:
    • Conventional Testing
    • Non-conventional Testing
  • Global Blood Stream Infection Testing Market, By Test Type:
    • Conventional Blood Culture Tests
    • PCR Method
    • Nucleic Acid Testing
    • Mass Spectroscopy
    • Point-of-Care Testing
  • Global Blood Stream Infection Testing Market, By End User:
    • Hospitals
    • Independent Diagnostics Centers
    • Others
  • Global Blood Stream Infection Testing Market, By Region:
    • North America
      • By Product Type:
        • Instruments
        • Reagents
        • Others
      • By Technology:
        • Conventional Testing
        • Non-conventional Testing
      • By Test Type:
        • Conventional Blood Culture Tests
        • PCR Method
        • Nucleic Acid Testing
        • Mass Spectroscopy
        • Point-of-Care Testing
      • By End User:
        • Hospitals
        • Independent Diagnostic Centers
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Instruments
        • Reagents
        • Others
      • By Technology:
        • Conventional Testing
        • Non-conventional Testing
      • By Test Type:
        • Conventional Blood Culture Tests
        • PCR Method
        • Nucleic Acid Testing
        • Mass Spectroscopy
        • Point-of-Care Testing
      • By End User:
        • Hospitals
        • Independent Diagnostic Centers
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Instruments
        • Reagents
        • Others
      • By Technology:
        • Conventional Testing
        • Non-conventional Testing
      • By Test Type:
        • Conventional Blood Culture Tests
        • PCR Method
        • Nucleic Acid Testing
        • Mass Spectroscopy
        • Point-of-Care Testing
      • By End User:
        • Hospitals
        • Independent Diagnostic Centers
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Instruments
        • Reagents
        • Others
      • By Technology:
        • Conventional Testing
        • Non-conventional Testing
      • By Test Type:
        • Conventional Blood Culture Tests
        • PCR Method
        • Nucleic Acid Testing
        • Mass Spectroscopy
        • Point-of-Care Testing
      • By End User:
        • Hospitals
        • Independent Diagnostic Centers
        • Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Instruments
        • Reagents
        • Others
      • By Technology:
        • Conventional Testing
        • Non-conventional Testing
      • By Test Type:
        • Conventional Blood Culture Tests
        • PCR Method
        • Nucleic Acid Testing
        • Mass Spectroscopy
        • Point-of-Care Testing
      • By End User:
        • Hospitals
        • Independent Diagnostic Centers
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Instruments
        • Reagents
        • Others
      • By Technology:
        • Conventional Testing
        • Non-conventional Testing
      • By Test Type:
        • Conventional Blood Culture Tests
        • PCR Method
        • Nucleic Acid Testing
        • Mass Spectroscopy   
        • Point-of-Care Testing
      • By End User:
        • Hospitals
        • Independent Diagnostic Centers
        • Others
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • BioMérieux SA*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Becton, Dickinson and Company
    • AB Sciex
    • IRIDICA
    • Abbot Laboratories
    • Cepheid Inc.
    • C. R. Bard, Inc.
    • F. Hoffmann-La Roche AG
    • Nanoshpere
    • Dade Behring
    • AdvanDX
    • Siemens Healthcare

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Technology
      • Market Snippet, By Test Type
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • PEST Analysis
    • Mergers and Acquisitions
    • Product Expiration
    • Regulatory Scenario
    • Pipeline Analysis
  4. Global Blood Stream Infection Testing Market, By Product Type, 2016 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Instruments
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Reagents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  5. Global Blood Stream Infection Testing Market, By Technology, 2016 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Conventional Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Non-conventional Testing      
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  6. Global Blood Stream Infection Testing Market, By Test Type, 2016 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Conventional Blood Culture Tests
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • PCR Method
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Nucleic Acid Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Mass Spectroscopy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Point-of-Care Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  7. Global Blood Stream Infection Testing Market, By End User, 2016 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Independent Diagnostics Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  8. Global Blood Stream Infection Testing Market, By Region, 2016 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2016 and 2026 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Test Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Test Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Test Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • Germany
        • U.K.
        • France        
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Test Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Test Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Technology, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Test Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
    • Company Profiles
      • BioMerieux SA
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Becton, Dickinson and Company
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • AB Sciex
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • IRIDICA
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Abbot Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cepheid Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • C.R.Bard, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • F. Hoffmann-La Roche AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Nanoshpere
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Dade Behring
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • AdvanDX
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Siemens Healthcare
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  10. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 22 market data tables and 20 figures on "Companion Diagnostics Market - Global forecast to 2026”.

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.